CHRONIC ENDOMETRITIS AS A PART OF REPRODUCTIVE LOSSES: NEW ASPECTS OF PATHOGENESIS (REVIEW OF LITERATURE)
Main Article Content
Abstract
An analytical review of modern sources of scientific literature on the pathogenesis of chronic endometritis and its effect on reproductive loss has been performed.
The analysis of 32 foreign and 11 domestic sources. The role of the association of complicated forms of the chronic inflammatory process in the tissues of the reproductive tract with the presence of polymorphic variants of hemostasis system genes is described. The prospect of studying the relationship of the gene mutation of the factor XIII hemostasis system with the formation of chronic endometritis, endometrial fibrosis, and habitual miscarriage is estimated.
The analysis shows that knowledge of the details of the pathogenetic mechanism will allow us to build a personalized rehabilitation strategy for the patient after an episode of miscarriage, pregravid preparation and accompanying subsequent pregnancy.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Suhih GT, Shurshalina AV. Chronic endometritis: Guide. M., 2013. 6 p. Russian (Сухих Г.Т., Шуршалина А.В. Хронический эндометрит: Руководство. М., 2013. 6 с.)
XVIII FIGO World Congress of Gynecology and Obstetrics, Kuala Lumpur, Malaysia. 2006, November 5-10
Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006; 12(6): 731-746. doi: 0,1093/humupd /dml004
Vartanyan EV, Martishkina EY, Caturova KA. The role of the combined pathology in the unsuccessful VF protocols. Obstetrics, Gynecology and Reproduction. 2011; 5(4): 40-43. Russian (Вартанян Э.В., Мартышкина Е.Ю., Цатурова К.А. Роль сочетанной патологии в неудачных протоколах ЭКО //Акушерство, гинекология и репродукция 2011. Т. 5, № 4. C. 40-43)
Agadzhanov AA. Actual methods of treatment of patients with recurrent pregnancy loss. Russian Medical Journal. 2003; 1: 3-7. Russian (Агаджанов А.А. Современные методы терапии больных с привычным невынашиванием беременности //Российский Медицинский Журнал. 2003. № 1. С. 3-7)
Pobedinskaya OS. Chronic endometritis in the genesis of miscarriage (spontaneous and non-developing pregnancies): abstract dis. … cand. med. sci. M., 2011. 24 p. Russian (Побединская О.С. Хронический эндометрит в генезе невынашивания беременности (спонтанные и неразвивающиеся беременности): автореф. дис. … канд. мед. наук. М., 2011. 24 с.)
Cicinelli E, Matteo M, Tinelli R, Pinto V, Marinaccio M, Indraccolo U et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014; 21(5): 640-647. doi: 10.1177/1933719113508817
Kasius JC, Fatemi HM, Bourgain C, Sie-Go DM, Eijkemans RJ, Fauser BC et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril. 2011; 96(6): 1451-456. doi: 10.1016/j.fertnstert.2011.09.039
Radzinsky VE. Reproductive Loss Prevention: Strategy and Tactics. Inform. bulletin. М.: StatusPraesens, 2014. 3-6 p. Russian (Радзинский В.Е. Предупреждение репродуктивных потерь: стратегия и тактика: Информ. Бюллетень. М.: StatusPraesens, 2014. С. 3-6)
Alubaeva NG. Clinical and immunological features of the course of chronic recurrent endometritis and the effectiveness of immunocorrective therapy: abstract dis. … cand. med. sci. Rostov on Don, 2008. 25 с. Russia (Алубаева Н.Г. Клинико-иммунологические особенности течения хронического рецидивирующего эндометрита и эффективность иммунокорригирующей терапии: автореф. дис. … канд. мед. наук. Ростов на Дону, 2008. 25 с.)
Unanian AL, Kossovich UM. Actual view of the problem of chronic endometritis. Consilium medicum. 2012; 14(6): 53-57. Russia (Унанян А.Л, Коссович Ю.М Современный взгляд на проблему хронического эндометрита //Consilium medicum. 2012. Т. 14, № 6. С. 53-57)
Lihacheva VV, Zorina VN, Tretyakova YN, Bazhenova LG, Tretyakova TV, Renge LV. Actual submission of the pathogenesis of chronic endometritis. The Russian Bulletin of the Obstetrician Gynecologists. 2017; 17(4): 25-32. Russian (Лихачева В.В., Зорина В.Н., Третьякова Я.Н., Баженова Л. Г., Третьякова Т.В., Ренге Л.В. Современные представления о патогенезе хронического эндометрита //Российский вестник акушера-гинеколога. 2017. Т. 17, № 4. С. 25-32)
Zheleznov BI. Structural changes in the uterine mucosa and ovarian function in chronic endometritis. Obstetrics and Gynecology. 1977; (4): 3-7. Russian (Железнов Б.И. Структурные изменения слизистой оболочки матки и функция яичников при хроническом эндометрите //Акушерство и гинекология. 1977. № 4. С. 3-7)
Espinosa G, Cervera R. Antiphospholipid syndrome. Arthritis Res Ther. 2008; 10(6): 230. doi: 10.1186/ar2536
Coppo P, Veyradier A. Thrombotic microangiopathies: towards a pathophysiology-based classification. Cardiovasc Hematol Disord Drug Targets. 2009; 9(1): 36-50. doi: 10.2174/187152909787581318
Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F et al. Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008; 632: 71-79. doi: 10.1007/978-0-387-78952-1_6
Demetz G, Ott I. The Interface between Inflammation and Coagulation in Cardiovascular Disease. Int J Inflam. 2012; 2012: 860301. doi: 10.1155/2012/860301
Ghosh AK, Vaughan DE. PAI-1 in Tissue Fibrosis. J Cell Physiol. 2012; 227(2): 493-507. doi: 10.1002/jcp.22783
Alotaibi FT, Peng B, Klausen C, Lee AF, Abdelkareem AO, Orr NL et al. Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis. PLoS One. 2019; 14(7): e0219064. doi:10.1371/journal.pone.0219064
Keillor JW, Apperley KY. Transglutaminase inhibitors: a patent review. Expert Opin Ther Pat. 2016; 26(1): 49-63. doi: 10.1517/13543776.2016.1115836
Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol. 2012; 95(4): 362-370. doi: 10.1007/s12185-012-1064-3
Dardik R, Solomon A, Loscalzo J, Eskaraev R, Bialik A, Goldberg I et al. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol. 2003; 23(8): 1472-1477. doi: 10.1161/01.ATV.0000081636.25235.C6
Mikkola H, Syrjala M, Rasi V, Vahtera E, Hamalainen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood. 1994; 84(2): 517-525
Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000; 96(3): 988-995
Novickyi VV, Goldberg ED, Urazova OI. Pathophysiology. GEOTAR-Med, 2009. P. 92. Russia (Новицкий В.В., Гольдберг Е.Д., Уразова О.И. Патофизиология. ГЭОТАР-Медиа, 2009. С. 92)
Cherkasskiy AV, Bashmakova NV, Tretyakova TB. Relationship building of blood coagulation, mutation of the gene encodes the a-subunit of coagulation factor XIII (F13A1) and severity of postoperative pelvic adhesions. Practical medicine. 2012; 9(65): 77-79. Russian (Черкасский А.В., Башмакова Н.В., Третьякова Т.Б. Взаимосвязь коагуляционного потенциала крови, мутации гена, кодирующего A-субъединицу XIII фактора свертывания (F13A1), и тяжести послеоперационного спаечного процесса органов малого таза //Практическая медицина. 2012. № 9(65). C. 77-79)
Laszlo M, Zsuzsanna B, Zsuzsa B, Istvan K, Eva K. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011; 91(3): 931-972. doi:10.1152/physrev.00016.2010
Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF. Fibroblast migration in fibrin gel matrices. Am J Pathol. 1993;.142(1):.273-283
Corbett SA, Lee L, Wilson CL, Schwarzbauer JE. Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem. 1997; 272(40): 24999-25005. doi: 10.1074/jbc.272.40.24999
Dardik R, Krapp T, Rosenthal E, Loscalzo J, Inbal A. Effect of FXIII on monocyte and fibroblast function. Cell Physiol Biochem. 2007; 19(1-4): 113-120. doi: 10.1159/000099199
Adamson R. Role of macrophages in normal wound healing: an overview. J Wound Care. 2009; 18: 349-351. doi: 10.12968/jowc.2009.18.8.43636
Glaros T, Larsen M, Li L. Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Front Biosci. 2009; 14: 3988-3993
Ichinose A, Asahina T, Kobayashi T. Congenital blood coagulation factor XIII deficiency and perinatal management. Curr Drug Targets. 2005; 6: 541-549. doi: 10.2174/1389450054545953
Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost. 2003; 29: 171-174. doi: 10.1055/s-2003-38832
Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost. 2009; 35: 426-438. doi: 10.1055/s-0029-1225765
Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscar-riages. Blood. 2003; 102: 4410-4412. doi: 10.1182/blood-2003-05-1467
Boda Z, Pfliegler G, Muszbek L, Toth A, Adany R, Harsfalvi J et al. Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report. Haemostasis. 1989; 19: 348-352. doi: 10.1159/000216082
Fisher S, Rikover M, Naor S. Factor 13 deficiency with severe hemorrhagic diathesis. Blood. 1966; 28: 34-39
Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest. 1990; 29: 235-238. doi: 10.1159/000293395
Rodeghiero F, Castaman GC, Di Bona E, Ruggeri M, Dini E. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Re-port of a second case. Blut. 1987; 55: 45-48. doi: 10.1007/BF00319641
Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X et al. Expression of urokinase, plasminogen activator inhibitors andurokinase receptor inpregnant rhesus monkey uterus during early placentation. Placenta. 2000; 21: 184-193. doi: 10.1053/plac.1999.0446
Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Placenta. 1999; 20: 711-721. doi: 10.1053/plac.1999.0425
Asahina T., Kobayashi T., Okada Y., Goto J., Terao T. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta. 2000; 21: 388-393. doi: 10.1053/plac.1999.0489